(I have decided to try, from time to time, to write about new publications in research on male breast cancer, and give a brief lay explanation of the findings and perhaps a comment. Here goes.) […]
Last week I attended a great cancer conference, the WIN Symposium which this year was titled “Personalized Cancer Therapy – from Innovation to Implementation”. This conference has brought together some of the best thinkers and […]
As promised on day 110, today I am writing about the drugs in the second phase of chemo that I am doing. FAC is a combination chemotherapy, made up of three different drugs, that can be thought of as variations on a single theme: inhibiting the co…
On day 38 I wrote about side effects and how they tell you things are working. Well, there are some that overshoot that mark a little, and can cause real harm. While no side effects are great, many are temporary and can be managed, such as hair lo…
This Wednesday was only my fourth taxol, but I am beginning to feel the side effects. It’s a little earlier than anticipated, and its nothing major. And of course, everyone’s experience is a little different. Mostly I have the feeling of cold feet…
After the detour last week related to the thyroid bump, and a busy, fun weekend with family events, things are settling down a little this week into a routine of work and ongoing chemo. And so I am in Washington DC today to participate in a regula…
When you get cancer at a younger age than is typical, this raises the suspicion that there is a genetic predisposition. For male breast cancer the typical age of incidence is in the mid 60s, and so I am 20 years ahead of the curve. That raises the…
Yesterday was my second chemo, and like the second time you do anything, was different from the first. It wasn’t all new, and yet it hasn’t exactly become routine either. It was a little odd. I am just at the three week mark, and it had been a flu…
Entering a World of Pink 